Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital

Warning LetterOpen

Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital, Number 10 and 12, Thillai Maistry Street Pondicherry 605001 Puducherry IndiaIssued Dec 22, 2025Center for Drug Evaluation and Research (CDER)

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations2

Issue DateDec 22, 2025

Product TypeDrugs

StatusOpen

Letter Details

Firm: Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital
Location: Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital, Number 10 and 12, Thillai Maistry Street Pondicherry 605001 Puducherry India
FEI Number: N/A
Country: India
Issue Date: December 22, 2025
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

In Vivo Bioavailability-Bioequivalence Studies – Clinical

Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital FDA Warning Letter, December 22, 2025